Unified Platform for Automated Developability Assessment and AI-Driven Predictive Modeling

Leveraging Genedata Screener for Biophysical Developability Assessment in Discovery Biologics Screening

Mass Spec Data Digital Transformation at Lilly Biologics Discovery

How Challenges in Biologics Development Catalyze Innovations in Cell Line Development

Japan: Thinking Plasma Biomarkers for Alzheimer’s Disease End-to-End

Unlocking NGS and Regulatory Synergy in GCT for Maximum Impact

NGS for Product Characterization in CGT: Biosafety and Genome Integrity

From Science to Compliance: Effective Validation of Genedata Selector

Discover What’s New in Genedata Screener 2026

Japan: Cutting Days from the DMTA Cycle in Discovery Research

Genedata Selector Product Development Roadmap

Japan: Driving Next-Generation Discovery with Organoids

Japan: Increasing Efficiency of Antibody Discovery and Engineering Workflows

Japan: Utilizing Genedata Biologics’ Versatility for Cloud Software Integrations

Therapeutic Antibody Profiling with Genedata Biologics — AI & ML Framework for Cancer Drug Discovery

Towards MAM in QC: Accelerating Adoption with Streamlined Data Analysis Strategies

Merck: Accelerating Precision Medicine: Using AI Assistants in GxP Environments

Exploring an AI-Native Approach to Antibody Discovery

Lessons Learned from a Global Genedata Deployment: Impact on Automation, Novel Modalities, and AI/ML

​Image Analysis with Machine Learning (ML) at Arvinas

Data, Data in the Well: Who’s the FAIRest of them all? A Tale of In Vitro Characterization of Biologics Preparing for the AI Era

Japan: Enterprise Analytics Platform for Biopharma Mass Spectrometry

Japan: Integrated Data Management for Multi-Modality Drug Development

Rapid Contamination Identification with Nanopore Sequencing

Automating Adventitious Agent Detection for GMP and Lot Release

Merck: Automating the DMTA Cycle for Faster Drug Discovery

Powering HT Protein Expression and Purification

A Multiplexed Platform for Covalent Ligand Screening

Democratizing NGS Analysis for Cell Line Development

Japan: Biopharma Discovery DX

Integrating Wet & Digital Labs to Accelerate Biologics Discovery

Fireside Chat: RNA Therapeutics & Data Innovation

Automating Data Analysis of High-Throughput RNA-Seq

Automating Data Analysis in Oligo Screening

Evotec’s Oligo Discovery: AI Design & RT-qPCR Screening

Data-Driven Oligonucleotide Discovery in RNAHub

Chemical Liability Screening for Biotherapeutic Protein Discovery

Digitalizing mRNA Workflows for Vaccines and Therapeutics

Enabling MS-Based MAM in QC Through a Robust New Peak Detection Workflow

Merck: X-Omics Platform Accelerates Precision Medicine